BioSante plans new prostate cancer drug testing
BioSante Pharmaceuticals Inc. said Monday it hopes to restart testing of an experimental prostate cancer drug almost two years after the research was stopped.
Read more on AP via Yahoo! Finance
BioSante plans new prostate cancer drug testing
WellPoint routinely targets breast cancer patients
WellPoint routinely targets breast cancer patients
Shortly after they were diagnosed with breast cancer, each of the women learned that her health insurance had been canceled. There was Yenny Hsu, who lived and worked in Los Angeles. And there was Patricia Reilling, a successful art gallery owner and interior designer from Louisville, Kentucky.
Read more on Reuters via Yahoo! News
Related posts
Ask the Doctor: Breast Cancer
Product Description
For the woman newly diagnosed or “at risk, ” this third book in Dr. Vincent Friedewald’s Ask the Doctor series demystifies breast cancer and helps readers sort through the confusing and conflicting reports that have been released to date. Dr. Friedewald details the steps involved in a thorough diagnosis, proven medical treatments, and what the patient (and her family and friends) can do to aid her recovery. Ask the Doctor series presents accessible medical informati… More >>
» Read more: Ask the Doctor: Breast Cancer